al-Bahar S, Pandita R, Hoffbrand A V
Department of Haematology, Kuwait Cancer Control Centre, Shuwaikh, Kuwait.
Acta Haematol. 1996;96(2):88-91. doi: 10.1159/000203722.
The complication of 'retinoic acid syndrome' occurs in 25-30% of patients with acute promyelocytic leukemia (APL) treated with all-transretinoic acid (ATRA). Early dexamethasone therapy has reduced mortality from this complication. No long-term sequel of the syndrome or its treatment with dexamethasone has been described. We report a patient with APL treated with ATRA who developed avascular necrosis of both femoral heads following treatment of retinoic acid syndrome with short-duration, high-dose dexamethasone.